The potential health gain and cost savings of improving adherence in chronic myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The potential health gain and cost savings of improving adherence in chronic myeloid leukemia

Published:2019-01-22 Issue:6 Volume:60 Page:1485-1492
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ector Geneviève I.C.G.¹^ORCID,Govers Tim M.¹²^ORCID,Westerweel Peter E.³^ORCID,Grutters Janneke P.C.⁴^ORCID,Blijlevens Nicole M.A.¹^ORCID

Affiliation:

1. Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;

2. MedValue, Nijmegen, The Netherlands;

3. Department of Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands;

4. Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1535113

Reference34 articles.

1. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

2. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

3. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

5. Chronic Myelogenous Leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring treatment decision-making in chronic myeloid leukemia in chronic phase;Frontiers in Oncology;2024-07-01

2. Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors;Oncology and Therapy;2023-12-16

3. Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey;Leukemia & Lymphoma;2023-06-06

4. A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase;Journal of Hematology & Oncology;2022-07-11

5. Multidisciplinary efforts in combating nonadherence to medication and health care interventions: Opportunities and challenges for operations researchers;IISE T HEALTHC SYST;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3